Zack Armen | executive |
Garo Armen | executive |
Steven O’Day | executive |
Robin Taylor | executive |
Christine Klaskin | executive |
Emily Bodnar | analyst |
Mayank Mamtani | analyst |
Matthew Phipps | analyst |
Thank you for standing by, and welcome to Agenus' First Quarter 2024 Results Conference Call. [Operator Instructions] I would now like to turn the call over to Zack Armen, Head of Investor Relations. Please go ahead.
Thank you, Rochelle, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and time lines, the goal of time lines for data release and partnership opportunities, among other updates.